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Ionotropic glutamate receptors (iGluRs) transduce
the chemical signal of neurotransmitter release into
membrane depolarization at excitatory synapses in
the brain. The opening of the transmembrane ion
channel of these ligand-gated receptors is driven by
conformational transitions that are induced by the
association of glutamate molecules to the ligand-
binding domains (LBDs). Here, we describe the
crystal structure of a GluA2 LBD tetramer in a con-
figuration that involves an 30 rotation of the LBD
dimers relative to the crystal structure of the full-
length receptor. The configuration is stabilized by
an engineered disulfide crosslink. Biochemical and
electrophysiological studies on full-length receptors
incorporating either this crosslink or an engineered
metal bridge show that this LBD configuration
corresponds to an intermediate state of receptor
activation. GluA2 activation therefore involves a
combination of both intra-LBD (cleft closure) and
inter-LBD dimer conformational transitions. Overall,
these results provide a comprehensive structural
characterization of an iGluR intermediate state.
INTRODUCTION
The a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) subtype ionotropic glutamate receptors (iGluRs) are
ligand-gated ion channels that mediate the majority of fast excit-
atory synaptic transmission in the brain (Traynelis et al., 2010). In
common with other iGluRs, each AMPA receptor subunit
includes four domains (Mayer, 2011). Closure of the extracellular
clamshell-like ligand-binding domains (LBDs) upon glutamate
binding is envisaged to open the gate of the cation-permeable
ion channel formed by the transmembrane domain (TMD). The
amino- and carboxy-terminal domains (ATD and CTD, respec-
tively) play only minor roles in AMPA receptor activation (i.e.,
gating). At present, only one crystal structure of a full-length
iGluR is available, that of the AMPA receptor GluA2, in an antag-
onist-bound, closed pore conformation (Protein Data Bank492 Neuron 79, 492–503, August 7, 2013 ª2013 Elsevier Inc.(PDB) ID 3KG2) (Sobolevsky et al., 2009). The four LBDs are in
an open cleft conformation, bound to the antagonist ZK200775
(Turski et al., 1998) and associate via interactions at the well-
characterized lobe 1 interface (Sun et al., 2002) into two dimers.
In the full-length GluA2 structure, the four subunits are named A,
B, C, and D. The two LBD dimers are formed by the A-D and B-C
subunits. We use the same nomenclature in the studies pre-
sented here.
To date, most studies of iGluR activation have considered
either the individual binding domains or the dimers of LBDs. To
understand properly how the concerted action of the LBDs
and the TMD drives glutamate receptor activation, it is essential
instead to work within the context of the four subunits in the
tetramer. The first step is to obtain knowledge of the functionally
relevant conformational states of the moving parts of the protein
assembly. A powerful strategy to achieve this goal is by engi-
neering artificial crosslinks between selected sites within the
protein to selectively trap functional states. Such crosslinks
have allowed the crystallization of nondesensitized and desensi-
tized LBD dimers (Armstrong et al., 2006; Weston et al., 2006)
and have also proved fruitful in studies of potassium channels
(Campos et al., 2007; Laine´ et al., 2003) and nicotinic receptors
(Mukhtasimova et al., 2009).
Here, we report the crystal structure of a crosslinked mutant
GluA2 LBD tetrameric assembly. The two LBD dimers are
rotated 30 relative to the dimers in the crystal structure of
the full-length receptor. This configuration is stabilized by a
disulfide bond between diagonally positioned subunits, A and
C, at cysteines introduced at position 665. Disulfide bond
formation also results in the LBD dimers being translated closer
together. Biochemical studies demonstrate that the same
C665-C665 crosslink can be formed in full-length receptors.
Electrophysiological studies of AMPA receptors with this cross-
link or separately engineered metal bridges suggest that these
conformational rearrangements between LBD dimers occur in
a functional state prior to full activation of the receptor.
RESULTS
Inter-LBD Dimer Crosslink
Little is known about conformational rearrangements between
iGluR LBD dimers during ion channel gating. However, cysteine
residues introduced in the loop between helices F and G of the
Figure 1. ADisulfide-Bridged GluA2-L483Y-
A665C LBD Tetramer
(A) A 2FoFc electron density envelope for the LBD
tetramer contoured at 2s is shown. Subunits A, B,
C, and D are shown in green, red, blue, and yellow,
respectively. DNQX is shown in purple.
(B) 2FoFc electron density for A655C contoured
at 1.5s is shown. The view is from ‘‘above’’ the
LBD layer. Subunits A and C are covalently linked
by the disulfide bond at position 655, which is
situated between helices F and G.
(C and D) The LBD tetramer from the crystal
structure of the full-length GluA2 receptor (Sobo-
levsky et al., 2009) is illustrated. The antagonist
ZK200775 is shown in purple. The A655 Ca-Ca
distance between subunits A and C, indicated by
the line, is 8.0 A˚.
(E) An illustration of the transition predicted by the
lowest-frequency normal mode going between the
OA (right) and CA (left) conformations is shown.
The OA conformation corresponds to the confor-
mation shown in (C), and the CA conformation
corresponds to the conformation shown in (A). The
angle that describes the relative orientation
between dimer pairs A-D and B-C has its vertex at
the center of mass of the Ca atoms of residue 665
in subunits A and C. The rays of the angle (cyan
arrows) pass through subunits A and C at the Ca
atom of Leu748.
See also Figure S1.
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units A and C and modify gating behavior (Armstrong et al.,
2006; Plested and Mayer, 2009; Sobolevsky et al., 2009). Similar
results have been obtained in the kainate receptor subtype
GluK2 (Das et al., 2010). The initial design of the A665C substitu-
tion (near the N terminus of helix G) that forms the interdimer LBD
disulfide crosslink studied here was based on a theoretical struc-
tural model of an LBD-TMD tetramer generated before the X-ray
structure of the full-length receptor was available (unpublished
data). In this model, the Ca atoms of A665 in subunits A and C
are 5 A˚ apart, 3 A˚ closer together than in the crystal structure
of the full-length receptor. We hypothesized that if such a trans-
lation of the LBDs by a few angstroms occurs in an intact recep-
tor, it could form an engineered disulfide crosslink, stabilizing a
conformationally distinct LBD tetrameric assembly.
Seeking structural insight into possible conformational states
within a tetrameric LBD layer, we determined the crystal struc-
ture of a GluA2-L483Y-A665C LBD mutant at 2.8 A˚ resolution
(Figure 1). The L483Y mutation was introduced in order to
stabilize LBD dimer formation (Sun et al., 2002). Each LBD is in
complex with the antagonist 6,7-dinitro-2,3-quinoxalinedione
(DNQX), which stabilizes an open conformation of the LBD clam-
shells. The asymmetric unit contains four LBD molecules, which
we call Mol1, Mol2, Mol3, and Mol4. Mol1 and Mol2 form a
‘‘back-to-back’’ dimer within the asymmetric unit, whereasNeuron 79, 492–50Mol3 and Mol4 are arranged ‘‘side-by-
side’’ (Figure S1 available online). Mol1-
Mol2 andMol3-Mol4 each form tetramers
when paired with their respective sub-units from adjacent asymmetric units in the crystal. These
tetrameric arrangements are physiologically plausible because
connections to the ATD and TMD are collectively located on
opposite sides of the tetramer, as seen in the structure of the
full-length receptor. Data collection and refinement statistics
are detailed in Table 1.
The root-mean-square deviations (rmsds) among the four
LBDs in the asymmetric unit (Mol1–Mol4) range from 0.3 to
0.7 A˚, with the difference in cleft closure, Dx12, varying from 0.1
to 0.7 A˚ (see Experimental Procedures). The back-to-back dimer
interfaces are very similar in the two physiological tetramers
formed by Mol1-Mol2 and Mol3-Mol4—the rmsd measured at
Ca atoms in helices D and J is 0.3 A˚. These dimers are very
similar to those observed in the full-length GluA2 crystal struc-
ture, with rmsds ranging from 0.4 to 0.6 A˚. Overall, the electron
density is stronger for chains Mol1 and Mol2 than for chains
Mol3 and Mol4. The following structural analysis will refer only
to the LBD tetramer formed by Mol1 and Mol2.
A single inter-LBD disulfide bond forms within the tetramer
between Cys 665 of subunits A and C (following the subunit
labeling of Sobolevsky et al., 2009). Electron density for the
C665-C665 disulfide bond is weak. This observation may reflect
incomplete disulfide bond formation in the crystal. In the crystal
structure of the full-length receptor, the distance between the Ca
atoms of A665 in subunits A and C is 8.0 A˚ (Figure 1D). This3, August 7, 2013 ª2013 Elsevier Inc. 493
Table 1. Data Collection and Refinement Statistics
GluA2-L483Y-A665C
Data Collection
Space group P21212
Cell dimensions (A˚)
a 48.85
b 96.79
c 252.84
Resolution (A˚) 52.92–2.80 (2.95–2.80)a
Rmerge 0.101 (0.270)
I/s 10.7 (4.3)
Completeness (%) 0.955 (0.923)
Redundancy 5.2 (5.1)
Refinement
Resolution (A˚) 52.92–2.80
Number of reflections 27,469
Rwork/Rfree 0.195/0.244
Number of atoms
Protein 7,904
Ligand/ion 87
Water 137
B factors
Protein 53.90
Ligand/ion 68.76
Water 32.63
Rmsds
Bond lengths (A˚) 0.001
Bond angles () 0.429
aValues in parentheses are for the highest-resolution shell.
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A Conformational Intermediate in iGluR Activationdistance is 5.4 A˚ between crosslinked LBDs (Figure 1B). It is
noteworthy that the LBDs of subunits A and C must be in open
cleft conformations for the crosslink to form. Modeling complete
closure of these LBDs increases the Ca-Ca distance at position
665 to 9 A˚, which is too great for disulfide bond formation.
Relative Orientation of LBD Dimers
The relative orientation of the two LBD dimers (subunit pairs A-D
and B-C) in the tetramer can be described by an angle between
the dimers. This angle is defined between two vectors that orig-
inate at the center of mass of the Ca atoms of residue 665 in sub-
units A and C and pass through the Ca atom of L748 in either
subunit A or C (Figure 1E). This angle is 145 in the crystal struc-
ture of the full-length receptor and 112 in the crystal structure of
the crosslinked LBD tetramer. We name these two interdimer
orientations the open angle (OA) conformation and the closed
angle (CA) conformation, respectively.
OA-to-CA transitions were examined using normal mode
analysis (NMA). In NMA, an effective harmonic potential energy
surface is assumed, and vibrations around the energy minimum
are calculated. Interest in NMA stems from the fact that low-
frequency modes have often been shown to provide a good
description of large conformational fluctuations observed exper-494 Neuron 79, 492–503, August 7, 2013 ª2013 Elsevier Inc.imentally around a stable conformation (Echeverria Riesco,
2011; Tama and Sanejouand, 2001; Temiz et al., 2004; Zheng
et al., 2006). Using the LBD tetramer from the crystal structure
of the full-length receptor as the reference conformation, we
generated a range of LBD tetramer conformations associated
with the lowest-frequency normal mode calculated using the
anisotropic network model (ANM) server (Eyal et al., 2006). Inter-
estingly, this simple low-frequency motion transformed the OA
conformation into the CA conformation, decreasing the Ca
rmsd with respect to the crystal structure of the crosslinked
LBD tetramer from 7.1 to 3.9 A˚ as well as decreasing the charac-
teristic angle from 145 to 113 (Figure 1E). The fact that the CA
conformation could be obtained by moving the structure along
the lowest-frequency normal mode, originating from the OA
conformation, is suggestive that OA-to-CA transitions could be
a genuine dynamical feature of the receptor.
Functional Trapping with A665C
Weperformed scanning cysteinemutagenesis between residues
658 and 670 to build a functional map of crosslinks at the inter-
dimer interface. Wild-type (WT) receptors are insensitive
to oxidizing or reducing conditions (Figure 2A). Cysteine sub-
stitutions within helices F or G produced mutant receptors that
exhibited a range of sensitivities. The R661C mutant, for ex-
ample, is almost as insensitive as the WT receptors (Figure 2B).
On the other hand, the I664C mutant is inhibited 80% by oxidi-
zation (Plested and Mayer, 2009), and the neighboring mutant,
A665C, exhibited 90% reduction in peak current amplitude
relative to reducing conditions (Figure 2C). Under reducing
conditions, A665C had similar activation and desensitization
kinetics to WT GluA2, suggesting limited functional impact of
the A665C substitution. Strikingly, a position-dependent reduc-
tion in peak current was observed upon oxidation for sites at the
end of helix F and within the loop between helices F and G (Fig-
ure 2D). Peak current measurements and molecular modeling
suggest that the A665C substitution is unlikely to result in cross-
links between receptors (Figure S2). The functional response is
therefore most likely due to crosslinks within receptors.
The A665C Mutation Traps Dimers
Although electrophysiological recordings demonstrate redox-
sensitive inhibition of AMPA receptors harboring the A665C
mutation, we sought to demonstrate that these cysteines could
participate in a physical crosslink between subunits. Western
blots showed that, as for purified WT GluK2 (Das et al., 2010),
WT GluA2 in lysates from HEK cells forms dimers spontaneously
under nonreducing conditions (Figure S3C). To provide a good
background for detecting dimerization due to the A665C muta-
tion, we generated GluA2 constructs lacking the cysteines not
involved in the two structural disulfide bonds (C63 and C315,
C718 and C773). Serial removal of cysteines lowered, but did
not eliminate, dimer formation in oxidizing conditions until we
removed all the remaining seven cysteines, indicating that dena-
turation allows natively buried cysteines to form confounding,
nonphysiological crosslinks. Receptors lacking these seven cys-
teines (GluA2 7 3 Cys ()) displayed similar rates of activation
and desensitization asWT in outside-out patches fromHEK cells
(kdes = 210 s
1; n = 3 patches), although currents were small,
Figure 3. The A665C Mutant Traps Dimers
(A) The GluA2-C89S-C190A-C436S-C425S-C528S-C589S-C815S (7 3
Cys ()) construct shows similar activation and desensitization to WT (kdes =
210 s1), but functional expression was strongly decreased.
(B) In western blots under oxidizing conditions, subunit dimers (D) were
strongly enriched, compared with the monomer band (M), for the 7 3 Cys ()
A665Cmutant, but not for the 7x() background. All reactions were performed
in the presence of 500 mM glutamate and 100 mMCTZ. MW, molecular weight;
Con, control; Red, reducing; Ox, oxidizing.
(C) Western blot analysis of 7 3 Cys () A665C mutant following in vivo
crosslinking. Cells were exposed to oxidizing conditions for 30 m in DNQX
(10 mM) or glutamate (500 mM and 10 mM). All conditions included CTZ.
(D) Fraction of dimer formation in reducing (open bars) and oxidizing (filled
bars) conditions. The dimer fraction in oxidizing conditions with 500 mM
glutamate was 30% ± 4% for the 73 Cys () A665C mutant (n = 11 blots). The
mutant R661C showed no significant increase in dimer formation over the
background (14% ± 2%; n = 5; p = 0.99 versus GluA2 7 3 Cys (); n = 6).
A665C showed a significant decrease in dimer formation in 10 mM glutamate
(14% ± 3%; n = 6; p = 0.026 versus 500 mM). There was no significant differ-
ence in dimer formation in the presence of DNQX (p = 0.41 versus 500 mM
glutamate; n = 5; Dunnett’s post hoc test).
See also Figure S3.
Figure 2. Trapping of the Full-Length GluA2-A665C Receptor
(A) Activation and desensitization of WT GluA2 were not affected by oxidizing
conditions. Single-exponential fits to the desensitization of responses to
10 mM glutamate in 1 mM DTT (control; kdes = 156 s
1, triangles and Wash
[washout]; kdes = 164 s
1, gray circles) and 10 mMCuPhen (kdes = 167 s
1, open
circles) are illustrated.
(B) Activation and desensitization of the R661Cmutant were similar in oxidizing
conditions (10 mM CuPhen, open circles, kdes = 239 s
1) and in reducing
conditions (1 mM DTT; control, triangles, kdes = 239 s
1; wash, gray circles,
kdes = 207 s
1).
(C) The A665C mutant shows a strong reduction of the peak current (90%)
under oxidizing conditions with a full recovery of the current after the re-
application of 1 mM DTT. The desensitization rate was similar before and after
the application of CuPhen (control kdes = 149 s
1, triangles; kdes = 175 s
1 after
washout in 1 mMDTT, gray circles). The inset shows the fit (dashed line) to the
current in oxidizing conditions.
(D) Bar graph representing the effect of CuPhen on the peak current in WT and
mutant receptors. Individual patches are shown as open circles. The strongest
inhibition in oxidizing conditions was for A665C (peak current 11% ± 4% of
that in reducing conditions; p < 0.0001 versus WT (***); one-way ANOVA with
Dunnett’s post hoc test). For R661C, the probability of no difference versus
control was 0.95; for V666C, p < 0.001 (**); for the other mutants, p < 0.01 (*).
The data for the I664C mutant are taken from Plested and Mayer (2009).
See also Figure S2.
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7 3 Cys () mutant was essentially monomeric on nonreducing
SDS-PAGE, even following 30 min of treatment with 100 mM of
the oxidizing agent copper phenanthroline (CuPhen; 12% ±
2% dimer; Figures 3B and 3C). In contrast, the GluA2 7 3 ()
A665C mutant spontaneously formed dimers in control condi-
tions (Figures 3B and 3C). Dimer formation was enhanced by
oxidizing conditions (100 mM CuPhen) and eliminated by treat-
ment with reducing agent (100 mM DTT).
To test if the crosslinking of subunits in GluA2-A665Cwas spe-
cific to functional receptors, i.e., those that could be controlled
by iGluR ligands, we tested for dimerization in various condi-
tions. A substantial dimer fraction was observed in the presenceof 500 mM glutamate (30% ± 4%; n = 11 blots). This dimerization
was specific to the introduction of cysteine at position 665
because the nearby R661C mutant, which exhibited minimal in-
hibition in electrophysiological assays, showed indistinguishable
dimer formation from the background in the same conditions
(14% ± 2%; n = 5; p = 0.99 versus GluA2 73 Cys (); Dunnett’s
post hoc test; Figures 3D and S3D). Dimerization of the A665C
mutant was reduced to control levels by crosslinking in the pres-
ence of 10 mM glutamate (14% ± 3%; n = 6 blots; p = 0.026
versus 500 mM glutamate; both with 100 mM cyclothiazide
[CTZ]; Figure 3D). Inclusion of DNQX and CTZ produced a level
of dimerization in between that of control (R661C) and A665C
with 500 mM glutamate, but the difference from either was not
significant (n = 5 blots, p = 0.41 versus A665C; p = 0.82 versus
R661C; Dunnett’s post hoc test).Neuron 79, 492–503, August 7, 2013 ª2013 Elsevier Inc. 495
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Our structural, biochemical, and electrophysiological findings
suggest that the LBD assembly can adopt a distinct CA confor-
mation that occurs readily in full-length receptors. The CA
conformation might be unstable in full-length receptors, but the
crosslinked LBD tetramer structure is stabilized by an inter-
subunit disulfide bond. The absence of the ATD and TMD
perhaps also allows the LBDs to adopt this configuration unhin-
dered. What then are the expected consequences of the CA
conformation in full-length channels? To investigate whether
OA-to-CA transitions in an intact receptor would require rear-
rangements of the ATD tetramer conformation, we measured
the distance between the Ca atoms of T394 (lobe 1 of the LBD,
proximal to the ATD). In an OA-to-CA transition, the pairwise
intersubunit distances would likely either decrease or stay about
the same (Table S1). Thus, consistent with aminimal role for ATD
transitions in gating, OA-to-CA transitions are predicted to not
disrupt the conformation of the ATD layer observed in the
full-length receptor structure.
One measure of the extent to which the four LBDs provide
impetus to gate the channel is the distances between LBD seg-
ments proximal to the TMD, i.e., the Ca atoms of P632, for each
pair of subunits (Lau and Roux, 2011; Sobolevsky et al., 2009).
We examined these distances in the crosslinked LBD tetramer
structure, the full-length GluA2 structure, and several modeled
conformations of the LBDs (Table S1). The analysis indicates
that the CA conformation results in greater P632-P632 distances
relative to the OA conformation. For example, the distances
between adjacent LBDs, i.e., subunits A-B and subunits C-D,
increase by 12 A˚, and the distances between diagonal LBDs,
i.e., subunits A-C and subunits B-D, increase by 8 and
24 A˚, respectively. This increase, however, is due not just to
OA-to-CA transitions but also to more open cleft conformations
in the LBDs of theCA conformation comparedwith the full-length
structure. Nonetheless, these observations suggest that adop-
tion of the CA conformation could potentially trigger ion channel
pore gating. How do P632-P632 distances change upon OA-to-
CA transitions versus LBD closure? To address this question,
open and closed LBD conformations were alternately modeled
into the OA and CA LBD tetramer conformations (Table S2).
For the A-D and B-C distances, larger changes are observed
upon LBD closure than upon OA-to-CA transitions. For the
A-B, C-D, and B-D distances, however, larger changes are
observed upon OA-to-CA transitions. For the A-C distance,
the largest change is seen for the OA-to-CA transition with
open LBDs.
The CA Conformation Occurs during Receptor
Activation
A marked feature of the CA conformation is that the upper lobes
from apposed LBD dimers are 16 A˚ closer together compared
with the OA conformation. We employed functional crosslinking
to detect the CA conformation in full-length, membrane-
expressed GluA2 during gating. Our strategy was to engineer
potential lobe 1-lobe 1 crosslinks at sites that are predicted to
change in proximity upon OA-to-CA transitions (Figure 4A). Our
initial attempts to engineer pairs of cysteine residues (K439C
and D456C) as substrates for bifunctional thiol reagents failed496 Neuron 79, 492–503, August 7, 2013 ª2013 Elsevier Inc.to produce functional channels. Single-cysteine control mutants
showed apparently normal gating (data not shown). We tried
exposing these double-cysteine mutants to EDTA in case a
high-affinity metal site was formed, to 30 mM DTT for up to
1 hr before recording, and to 1 mM DTT overnight during cell
culture, but we never obtained recordings of this mutant. To
obtain trappable mutants that were also functional, we turned
to engineered metal trapping bridges (Figures 4A and 4B). We
screened 11 combinations of histidine and cysteine residues
and found two triple-histidine mutants and two double-histidine
single-cysteine combinations, where 1 mM zinc selectively
reduced the glutamate-gated current by 50% over nominally
divalent-free conditions (2 mM EDTA). Representative traces
from WT GluA2, an insensitive mutant, and the GluA2-G437H-
K439H-D456H mutant (named HHH) are shown in Figure 4C.
Most control mutants were functional, but like WT receptors,
none showed inhibition by 1 mM zinc (Figure 4D). Despite
differing in local stereochemistry, the four triple mutants all
have similar sensitivities. This observation suggests that the inhi-
bition is not a nonspecific effect of structural disruption but,
rather, a general property resulting from restraining the receptor
in the CA conformation. Using the GluA2 7 3 Cys () back-
ground, we inserted cysteines in positions K439C and D456C.
Although this double mutant was not functional, western blots
revealed modest redox-sensitive dimer formation in oxidizing
conditions (Figure 4E), in excess of the limited dimerization of
single mutants (Figures 4F and S3).
State Dependence of Receptor Trapping
Our cysteine scan shows that crosslinking can occur at sites in
the loop between helices F and G and reduce the peak current
in response to glutamate application. Receptors were exposed
to oxidizing conditions for a series of glutamate applications at
1 Hz, allowing them to transition through all functional states
during the glutamate pulse and in the 1 s interval before the
subsequent pulse. Thus, these measurements did not reveal if
disulfide formation was preferred in any particular functional
state, such as the resting, desensitized, or activated state. To
identify the state in which the A665C mutation traps GluA2, we
performed patch-clamp recordings of receptors in outside-out
patches biased into specific states, detecting trapping as a
loss of glutamate-activated current following exposure to
10 mM CuPhen.
Applying oxidizing conditions to GluA2-A665C mutant recep-
tors during desensitization (100 mM glutamate in the absence of
CTZ) for 1 s did not lead to appreciable inhibition (data not
shown). However, longer oxidizing exposures in desensitizing
conditions (>30 s) stably inhibited the glutamate-activated
current. The time constant of recovery was too slow to estimate
reliably because measurements over minutes were hindered by
rundown of the patch current. This stable desensitized trapping
probably contributed to the strong inhibition of the A665C
mutant shown in Figure 2C.
To avoid confounding effects of receptor desensitization when
probing the resting and activated states, and to mimic the
conditions of the GluA2-L483Y-A665C crystal structure, we
attempted to use an L483Y-A665C double mutant for subse-
quent electrophysiology. This mutant, however, greatly reduced
Figure 4. EngineeredMetal BridgesConfirm
the CA Conformation in the Full-Length
Receptor during Activation
(A and B) The engineered HHH metal bridge is
formed by the triple-histidine mutation G437H-
K439H-D456H (blue spheres at a carbons). Metal
bridges cannot form when the LBDs are in the
OA conformation (A) but can form when they are
in the CA conformation (B). The direction of view
is the same as in Figure 1E. Only subunits A and
B are shown for clarity.
(C) Zinc (1 mM) selectively inhibits a triple-histidine
mutant that is predicted to compose an interdimer
metal bridge in the CA conformation, but not WT or
a mutant with half the site.
(D) Summary of inhibition by 1 mM zinc for WT, half-
sites, controls, and the four triple mutants that
show inhibition.
(E) The double-cysteine mutant (K439C-D456C)
was not expressed as a functional glutamate
receptor, but western blot analysis of total cell
lysate revealed redox-sensitive trapping of dimers.
(F) Fraction of dimer formation in reducing (green
bar) and oxidizing conditions (purple bars). Dimer
formation was observed for the 7 3 Cys ()
K439C-D456C (KD) mutant (43% ± 5% in oxidizing
conditions; p < 0.05 versus K439C single mutant
(*), and p < 0.01 versus reducing conditions [**]).
The dashed line shows dimer formation for the 73
Cys () WT construct in oxidizing conditions. The
number of blots is indicated in each bar.
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A Conformational Intermediate in iGluR Activationcell viability upon transfection, and we were unable to record
responses from surviving cells. Instead, we used 100 mM
CTZ to block desensitization, which should mimic the effects
of the L483Y mutation (Sun et al., 2002). At the end of a 1 s
application of 10 mM glutamate, the steady-state current wasNeuron 79, 492–5100% ± 1% (n = 14) of the initial peak
current for WT and 98% ± 1% (n = 14) of
the peak for the mutant GluA2-A665C
(Figure S4). This result shows that desen-
sitization was almost entirely absent in
experiments on the A665C mutant per-
formed with CTZ and, taken together
with other experiments on the HHH
mutant described below, rules out the
possibility that the CA conformation
represents a state associated with
desensitization.
We held A665C receptors in the resting
state by saturating them with 10 mM
DNQX in addition to 100 mM CTZ. These
receptors did not show a loss of gluta-
mate-activated current following expo-
sure to 10 mM CuPhen, suggesting that
A665C does not appreciably form cross-
links in the resting state (Figures 5A and
S4). Apo A665C receptors and those
bound with 30 mM 6-cyano-7-nitroqui-
noxaline-2,3-dione (CNQX) were similarlyrefractory to trapping when CTZ was included (data not shown).
Trapping was again barely detectable when the receptors were
saturated with 10 mM glutamate and 100 mM CTZ (Figure 5A),
indicating that the crosslink also does not trap the receptor in
a fully activated state.03, August 7, 2013 ª2013 Elsevier Inc. 497
Figure 5. The A665C Crosslink Traps an
Activation Intermediate that Is Not Satu-
rated with Agonist
(A) Responses to 10 mM glutamate in 1 mM DTT
(green bars) flanking an application of 10 mM
CuPhen (red bars) in the DNQX-bound resting
state (1 s; top trace) and open state (3 s; middle
trace) reveal negligible trapping. A substantial
trapping relaxation was observed in the presence
of an intermediate glutamate concentration (t =
0.5 s; 500 mM; lower trace, red circles). CTZ
(100 mM) was present throughout.
(B) The active fraction of receptors after oxi-
dization in the presence of 10 mM DNQX (purple),
10 mM glutamate (blue), and 500 mM glutamate
(yellow, exponential fit) is plotted against the
trapping interval. The open red circles represent
the mean of exponential fits to the trapping relax-
ation (as in A). Arrows indicate intervals for the
traces in (A) (n = 3–6 patches per point).
(C) Trapping in oxidizing conditions at different
concentrations of glutamate is presented. In the
top panel, three records from the same patch
show trapping in CuPhen (red bar) with 10 mM
(light-blue trace), 500 mM (orange trace), and
10 mM glutamate (dark-blue trace). Robust
trapping only occurs in 500 mM glutamate
(expanded scale, middle panel). The open red
circles are a mono-exponential fit to the
relaxation (same fit as in A, lower trace, and B).
The arrows and symbols indicate the measure-
ments plotted in (D). WT GluA2 was not modified
by oxidization (lower panel, red bar) in 500 mM
glutamate.
(D) Concentration-response curves in CuPhen
and 100 mM CTZ for WT GluA2 (blue open
circles; EC50 = 270 ± 140 mM), GluA2 A665C
following reduction (green triangles; EC50 = 530 ±
160 mM), and following trapping (red squares;
EC50 = 1.9 ± 0.2 mM). The difference between the reduced and oxidized (trapped) A665C mutant is significant (p < 0.001). Plotting the active fraction current
after trapping (yellow diamonds) versus glutamate concentration reveals maximal trapping at 248 mM glutamate (n = 5).
See also Figures S4, S5, and S6.
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trapping at concentrations of glutamate over the range 100 mM
to 2 mM. The exponential decay of the current following the
jump into oxidizing conditions at 500 mM glutamate (t = 500 ±
100 ms; n = 5) was indistinguishable from the extent of trapping
plotted against different time intervals (t = 400 ± 100 ms; Fig-
ure 5B), suggesting that this relaxation reflects the inhibition
due to formation of the disulfide bond. WT receptors showed
no inhibition in oxidizing conditions when activated by 500 mM
glutamate (Figure 5C). The relationship between the active
(untrapped) fraction and log concentration followed an inverted
bell shape and thus waswell described by an inverted log normal
function with a minimum at 248 mM (Figure 5D). Kinetic simula-
tions of channel activation demonstrated that this relationship
mandates trapping in partially bound states (Figure S5). Cross-
linking also lowered apparent glutamate potency, consistent
with a reduced occupancy of the receptor by glutamate
(Figure 5D). Consistent with strong trapping being associated
with incomplete activation, saturating the receptor with the
partial agonist kainate also promoted trapping (data not shown;498 Neuron 79, 492–503, August 7, 2013 ª2013 Elsevier Inc.see Discussion). We obtained similar results by oxidizing with
5,50-dithiobis-(2-nitrobenzoic acid) (DTNB) in the presence of
heavy metal chelators (Figure S6), demonstrating that the
absence of trapping at high glutamate concentrations is not
due to copper chelation and consequent loss of oxidizing activ-
ity. The inhibitory effect of DTNB was less strong than that of
CuPhen, leading to a smaller rightward shift in the glutamate
concentration response curve. The weak action of DTNB is
unsurprising given that it is approximately twice as bulky as
phenanthroline and that the interdimer region is closely packed.
Poor access of DTNB to the cysteines at position 665 probably
results in a mixed population of receptors with reduced and
intact crosslinks (Gielen et al., 2008).
Zinc bridging between subunits inhibited the HHH mutant
with an apparent affinity of 95 ± 30 nM (Figure 6A). We exploited
multibarrel fast perfusion to assess the state dependence of
this zinc bridging in the HHH mutant. Consistent with the struc-
ture of the full-length receptor, we could not detect inhibition
due to zinc bridging at rest, and zinc alone did not activate a
current in the presence of CTZ (n = 6 patches). No inhibition
Figure 6. State Dependence of Lobe 1 Metal
Sites
(A) The half-maximal inhibitory concentration of
zinc for the mutant G437H-K439H-D456H (HHH,
yellow circles) was 95 ± 30 nM (n = 4).
(B) Voltage-independent inhibition by zinc (Zn2+;
1 mM, red bar) at intermediate glutamate concen-
tration (500 mM, 60 and +60 mV) is shown. The
lower dashed line shows the average size of the
control responses to 10 mM glutamate in EDTA
(green bars). The lower trace shows a mono-
exponential fit to trapping relaxation (red circles, t =
220 ms) and the slow component of a double
exponential fit to current in EDTA (green bar)
following trapping (green circles, loss of zinc trap-
ping, t = 550 ms; amplitude 33%).
(C) State dependence of inhibition by 1 mM zinc (n =
3–6 patches per point). Zinc preferentially traps a
partially glutamate-bound state (yellow, 500 mM
Glu + CTZ).
(D)WT receptors are not trapped by 1 mMzinc in the
presence of 500 mM Glu plus CTZ.
(E) Concentration-response curves in 1 mMzinc and
100 mM CTZ for WT GluA2 (blue open circles;
EC50 = 140 ± 10 mM), GluA2HHHbefore trapping by
zinc (green triangles; EC50 = 230 ± 27 mM), and
GluA2 HHH following trapping (red squares; EC50 =
424 ± 30 mM). The difference between the apparent
affinities for glutamate in the presence and absence
of zinc was significant (p < 0.01). Plotting the active
fraction current after trapping (yellow diamonds)
versus glutamate concentration reveals maximal
trapping at 368 mM glutamate (n = 3).
(F) Top view of the CA conformation of the LBD
tetramer modeled with two interdimer triple-
histidine mutants coordinating zinc ions is pre-
sented. The right panel shows the boxed region
from the left panel on an expanded scale.
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A Conformational Intermediate in iGluR Activationwas seen following desensitizing exposures (100 mM glutamate
without CTZ), at rest or after full activation (10 mM glutamate
with CTZ). However, robust voltage-independent trapping was
observed following exposure to 500 mM glutamate (Figures 6B
and 6C). This inhibition was absent from WT GluA2 in equivalent
conditions (Figure 6D). The lack of inhibition at high glutamate
concentration was not due to chelation of zinc into zinc-gluta-
mate complexes because we still observed robust inhibition
when the patches were washed with 1 mM zinc, 500 mM L-gluta-
mate, and 9,500 mM D-glutamate, which barely activates the
receptor but should chelate zinc equally well. The glutamate
dependence of trapping was similar to that of the A665C
mutant, with a maximum extent of trapping at 348 mM glutamate
(Figure 6E). Thus, the zinc-binding site created by the HHH
mutant, which was suggested by the crosslinked crystal struc-
ture, also traps a partially bound state and does so with more
specificity than the A665C mutant. Structural modeling of the
HHH mutant built using our LBD tetramer structure, where
only residues 436–440 and 455–457 (those flanking the HHH
substitutions) were repositioned using energy minimization,
shows that a zinc ion can be cradled by the three histidines
(Figure 6F). The repositioned residues all lie in loop regions,and the rmsd measured at the Ca atoms of these residues is
only 0.75 A˚. These observations constitute strong evidence
that the crystallized CA conformation occurs in the full-length
receptor when some, but not all, of the ligand-binding sites
are occupied by glutamate.
Structural modeling was pursued to examine possible conse-
quences of OA-to-CA conformational transitions that occur in
conjunction with LBD closure in subunits B and D on ion channel
pore opening. First, the closure of subunits B and D in the crystal
structure of the crosslinked LBD tetramer was modeled by
superimposing the structure of a closed, glutamate-bound
LBD (PDB ID 1FTJ; chain A) (Armstrong and Gouaux, 2000) at
helices D and J in lobe 1. Next, the TMD from the full-length
GluA2 crystal structure was allowed to relax energetically to
accommodate the LBDs (Figure S7). In this model, the inner
transmembrane helices (M3) are predicted to widen at the ion
channel gate between subunits B and D by 11 A˚, as measured
between Ca atoms of T625. It should be noted that NMA
was attempted with both the full-length GluA2 structure and
the isolated TMD, but the ion channel gate could not be opened
in either case, likely due to the tight network of residues around
the gate.Neuron 79, 492–503, August 7, 2013 ª2013 Elsevier Inc. 499
Figure 7. Proposed Structural Transitions
Involved in AMPA Receptor Activation
Subunits A, B, C, and D are colored green, red,
blue, and yellow, respectively. The LBDs are
arranged in the OA conformation when the re-
ceptor is in a state of rest. When the LBDs of
subunits B and D bind glutamate (orange
sphere), the receptor enters a state of partial
activation. In this state, the LBDs may adopt
either the OA or CA conformation. The confor-
mation trapped by either the disulfide bridge
formed by the A665C mutation or the metal
bridge formed by one of the triple-residue
mutations is indicated by an asterisk. When
glutamate is bound to all LBDs, the receptor
enters a state of full activation. We have no information about the LBD conformation in this state. It is unknown whether the ATD layer undergoes large-scale
structural rearrangements during gating transitions, and it is therefore omitted from this figure. See also Figure S7 and Table S1.
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Over 80 crystal structures of the isolated GluA2 LBD have been
reported to date (Pøhlsgaard et al., 2011). These structures, in
concert with biochemical and biophysical experiments, and
molecular simulation studies, have characterized the processes
of ligand binding and domain closure, which are directly linked to
receptor activation (Armstrong and Gouaux, 2000; Dong and
Zhou, 2011). Less is known, however, about the possible intersu-
bunit conformational rearrangements in iGluR tetramers that
could underlie ion channel gating. The only structural information
to date linking the LBDs to the TM pore domain is the resting
state arrangement captured in the crystal structure of the full-
length receptor. Here, through a combination of structural,
biochemical, and electrophysiological studies and computa-
tional modeling, we have identified a distinct LBD tetramer
conformation that corresponds to an intermediate state of
receptor activation. This state can be trapped by the A665C
mutation, which forms a disulfide bridge between the A and C
subunits. Our crystal structure predicts that we should also be
able to bridge subunits A and B and subunits C and D in the
CA conformation. Triple substitutions in lobe 1, such as the
HHH mutant, confirm this prediction by forming zinc-binding
sites that trap a state of intermediate activation. Zinc bridging
with the HHH mutant does not trap antagonist-bound, fully
active, and desensitized states, making it more state specific
than the A665C crosslink. The difference in specificity could be
explained by a greater separation of the constituents of the
HHH site in the antagonist-bound and other states.
A depiction of the trapped state in the CA conformation within
the context of proposed transitions between various stages of
receptor activation is provided in Figure 7. The engineered metal
trapping between the upper lobes is unexpected on the basis of
existing structural information and is both geometrically and
stereochemically distinct from previous unsuccessful attempts
to find interdimer contacts (Horning and Mayer, 2004). The inter-
mediate state that is trapped is likely to be unstable in WT recep-
tors because there is no extensive interface between dimers. It is
tempting to speculate that this lack of interface is an evolved
property essential for the rapid kinetics of AMPA receptors, but
NMDA receptorsmay differ (see below). Both the disulfide bridge500 Neuron 79, 492–503, August 7, 2013 ª2013 Elsevier Inc.and the metal bridges form interactions between LBD dimers,
and both types of bridges functionally inhibit the receptor,
perhaps because they hinder full domain closure, or perhaps
because they restrain a conformational transition essential to re-
ceptor activation.
Biochemical and electrophysiological measurements confirm
that the A665C crosslink observed in the LBD tetramer crystal
structure is redox sensitive in full-length receptors. The crosslink
readily inhibits receptors during conformational transitions
related to ion channel gating and selectively traps pairs of sub-
units. Consistent with the crystal structure of the full-length
GluA2, in which the Ca atoms of A665 in subunits A and C are
separated by 8.0 A˚, crosslinking in the presence of antagonist
(10 mM DNQX with the LBD dimers stabilized by CTZ) occurs
very slowly (no effect within 30 s), if at all. This observation sug-
gests that, in GluA2, disulfide bond formation at this site is a sen-
sitive reporter of distances. Consistent with the functional
studies, structural modeling of glutamate-bound LBDs into the
tetramer as well as biochemical experiments also suggest that
the A665C residues are too far apart for disulfide bond formation
when the LBDs in subunits A and C are closed, such as when the
receptor is saturated with agonist and not desensitized. This key
observation explains why the CA activation intermediate was
captured in the crystal even though the LBDs were occupied
by DNQX: the A and C subunits must be held open for crosslink-
ing, whereas the B and D subunits are free to close without dis-
turbing the crosslink. The B and D subunits are therefore likely
bound with agonist when the crosslink forms at C665 in the
full-length receptor. Given the incomplete inhibition by oxidizing
conditions, this partially glutamate-bound configuration prob-
ably allows ion conduction, consistent with the notion that
closure of the LBDs in the B and D subunits alone is sufficient
to activate the receptor (Das et al., 2010).
Several of our observations suggest that the A665C mutant
can be trapped, albeit slowly, in other conformational states.
Desensitization may promote disulfide bond formation when
the receptor is saturated by glutamate, but the geometry of
such a desensitized, crosslinked tetramer is expected to be
different from that seen in our crystal structure in that the lobe
1 dimer interface would be ruptured (Armstrong et al., 2006).
Trapping that we observed in the combined presence of kainate
Neuron
A Conformational Intermediate in iGluR ActivationandCTZ suggests that the A665C sitemoves to a similar position
seen in our crystal structure when a dimer is saturated with
kainate aswhen one subunit in a dimer is occupied by glutamate.
Stabilizing the LBDs in a nondesensitized, inactive conformation
(DNQX plus CTZ) blocked trapping completely in functional ex-
periments. In biochemical experiments, the degree of trapping
in DNQXwas not significantly different from that for either control
(e.g., R661C) or A665C in 500 mMglutamate, suggesting the pos-
sibility that oxidizing exposures much longer than those relevant
for channel gating could drive the receptor into a conformation
resembling the crystallized CA conformation. However, the low
signal-to-noise ratio of our biochemical experiments rules out
any conclusive interpretation of these data.
The selective zinc inhibition of the four triple-substitution
mutants that we report, including the HHH mutant, can only
occur if lobes 1 of apposed LBD dimers approach sufficiently
to create a metal-binding site. Forming this site requires a
16 A˚ translation of the upper lobes. To our knowledge, such a
movement has not been previously documented in the litera-
ture. Because the composition and exact geometry of this site
seem less important than the presence of three coordinating
groups, inhibition due to some local distortion within individual
domains seems unlikely. Relatively large OA-to-CA motions
therefore occur between dimers as the receptor transitions
from the resting state to the fully activated state. In NMDA
receptors, loops 1 and 2 of the LBD are proposed to mediate
interactions between glycine-binding GluN1 and glutamate-
binding GluN2 subunits (Regalado et al., 2001). A CA-like
conformation would allow loop 1 of each GluN2 subunit to con-
tact GluN1 in the adjacent dimer, stabilize a partly bound LBD
tetramer, and produce the apparent negative cooperativity of
glycine and glutamate binding.
Both agonist occupancy of AMPA receptors (Rosenmund
et al., 1998; Smith and Howe, 2000) and the average closure
of their LBDs (Jin et al., 2003) control the amplitude of single-
channel events, which in turn determines the charge transfer
of synaptic currents. Interdimer translations (to reduce linker
separation) and OA-to-CA transitions (to increase linker separa-
tion) present additional degrees of freedom that could be
reflected in the complexity of AMPA receptor activation. Our
recordings show that interdimer translation and rotation to the
CA conformation occur preferentially when the receptor is
partially glutamate bound. This intermediate conformation could
contribute to the nonlinear increase in conductance with occu-
pancy (Rosenmund et al., 1998), in which singly occupied
receptors do not appreciably gate, and the single channel con-
ductance for apparently doubly occupied receptors is small and
noisy. AMPA receptors also exhibit gating modes that may
involve the CA conformation (Prieto and Wollmuth, 2010). We
are actively pursuing single-channel recordings from the mutant
receptors described in this manuscript in order to probe these
possibilities.
Activation intermediates have been detected functionally as
sublevels in the AMPA receptor and as short-lived closed states
in other neurotransmitter receptor families (Burzomato et al.,
2004; Grosman et al., 2000; Mukhtasimova et al., 2009; Rose-
nmund et al., 1998). Here, we describe the molecular geometry
underlying such a structurally distinct intermediate for a ligand-gated channel. Future experiments may address the intriguing
possibility that the binding of additional glutamate molecules
may drive the LBD layer into other structural arrangements
that accompany either unitary events of higher amplitude or
desensitization.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The plasmid pET22b(+)GluR2S1S2J (Armstrong and Gouaux, 2000) used to
express the GluA2 LBD protein was kindly provided by Eric Gouaux. This
construct has eight histidines at the N terminus, followed by sites for thrombin
and trypsin digestion. The L483Y and A665Cmutations were introduced using
the QuikChange Site-Directed Mutagenesis Kit (Agilent). The mutations were
confirmed by DNA sequencing. The double-mutant protein was overex-
pressed in Origami B(DE3) cells (Novagen). The cells were disrupted using
an Avestin EmulsiFlex homogenizer. The GluA2-L483Y-A665C protein was
purified from the soluble fraction using a 5 ml HiTrap Chelating HP column
(GEHealthcare) chargedwith nickel. The N-terminal histidine tag was removed
by trypsin (Sigma-Aldrich) digestion.
Crystallization
The protein sample was dialyzed against 10 mM HEPES at pH 7.0, 20 mM
NaCl, 1 mM EDTA, and 1 mM DTT using a 12–14 kDa molecular weight cutoff
(MWCO) membrane to remove glutamate. The dialyzed sample was then
adjusted to 10% glycerol. The protein was concentrated to 12 mg/ml using
an Amicon Ultracentrifugal filter device (Millipore) with a 10 kDa MWCO. The
final concentration of DNQX (Tocris Bioscience) added to the protein solution
was 3 mM. Crystals were grown at 4C in hanging drops containing a 1:1 (v/v)
ratio of protein solution to reservoir solution. The crystallization buffer con-
tained 19% PEG 1450, 300 mM lithium sulfate, and 100 mM sodium cacody-
late at pH 6.5. The crystals were soaked in crystallization buffer supplemented
with 10% glycerol and 3 mM DNQX prior to flash freezing in liquid nitrogen.
Structure Determination and Refinement
X-ray diffraction data were collected at the Advanced Photon Source (Argonne
National Laboratory) at beamline 23-ID-D using a MARMOSAIC 300 CCD
detector. A wavelength of 1.0332 A˚ was used. The temperature of the crystal
was100 K. The data were indexed, integrated, and scaled using Mosflm and
Scala from the CCP4 suite of programs (Potterton et al., 2003). The structure
was solved by molecular replacement using Phaser (McCoy et al., 2007).
The LBD-L483Y-DNQX dimer structure (PDB ID 1LB9) (Sun et al., 2002) was
used as the search probe. Model building and crystallographic refinement
were performed using Coot (Emsley et al., 2010) and PHENIX (Adams et al.,
2010) until the R/Rfree values converged.
Structural Analysis and Molecular Modeling
The amount of domain closure in each LBD is determined according to two
center-of mass distances x1 (between residues 479 and 481 in lobe 1 and
residues 654 and 655 in lobe 2) and x2 (between residues 401 and 403 in
lobe 1 and residues 686 and 687 in lobe 2) (Lau and Roux, 2007, 2011). A
one-dimensional projection of these distances is x12 = (x1 + x2)/2.
Rigid body rotation of the LBD dimers was performed using CHARMM
(Brooks et al., 2009). The model of how the LBD tetramer 2 conformation
(see Table S1) might influence the ion channel gate was also generated using
CHARMM. NMA was performed using the ANM server (Eyal et al., 2006).
For modeling of the zinc-binding sites, mutant histidine residues were built
using SCWRL4, and the zinc ion was roughly centered between the side
chains. The loop segments containing the histidines and the zinc were sub-
jected to energy minimization with CHARMM, with the histidines and zinc
restrained to be in close proximity. The rest of the model was held fixed.
Electrophysiology
The flip splice variant ofGluA2was used for electrophysiology studies.Mutants
were generated using overlap PCR. The presence of the mutant codons was
corroborated by double-stranded DNA sequencing of the amplified region.Neuron 79, 492–503, August 7, 2013 ª2013 Elsevier Inc. 501
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HEK293 cells for outside-out patch recording. The external solution in all the
experiments contained 150 mM NaCl, 0.1 mM MgCl2, 0.1 mM CaCl2, 5 mM
HEPES, titrated to pH 7.3 with NaOH, to which we added different drugs either
in oxidizing or reducing conditions. For metal-bridging experiments, we
included either 1 mM zinc, or 2 mM EDTA to chelate trace divalent ions, and
readjusted the pH to 7.3. Drugs were obtained from Tocris, Ascent Scientific,
or Sigma-Aldrich. The CuPhen solution wasmade at 1:3molar ratio (CuCl2 dis-
solved in water and 1,10-phenanthroline dissolved in EtOH) to obtain a final
concentration of 10 mM. The pipette solution contained 115 mM NaCl,
10 mM NaF, 0.5 mM CaCl2, 1 mM MgCl2, 5 mM Na4BAPTA, 5 mM HEPES,
and 10 mM Na2ATP (pH 7.3). All the patches were voltage clamped between
30 and 60 mV. Currents were filtered at 1–10 kHz (3 dB cutoff, eight-
pole Bessel) and recorded usingAxograph X (AxographScientific) via an Instru-
tech ITC-18 interface (HEKA). The sampling rate was 20 kHz. The rate of onset
of desensitization (kdes) was established by fitting a single exponential function
to the decay in response to a long pulse of glutamate.
We applied drugs to outside patches via a perfusion tool made from custom-
manufactured four-barrel glass (VitroCom). To measure the state dependence
of trapping in oxidizing conditions, we determined the baseline for activation
by 10 mM glutamate in the presence of 5 mM DTT (300 ms pulses at a
frequency of 1 Hz). Following a brief (usually 1 s) pause for recovery from
desensitization, oxidizing conditions (usually CuPhen, 10 mM) were applied
via the third barrel of the perfusion tool, for 30 ms to 10 s (see Figure S4). To
bias the receptor into particular states, we coapplied antagonist or different
concentrations of glutamate (in the presence of 100 mM CTZ). After this treat-
ment, we immediately monitored the percentage of current modified, and the
recovery from trapping, by applying a pulse of 10mM glutamate again in 1 mM
DTT for 300 ms. We fitted the relaxation in 10 mM glutamate with a double
exponential function. The fast component (time constant z1 ms) was the
activation by glutamate, and the slow was the untrapping relaxation, which
was absent in WT channels. Following coapplication of 10 mM DNQX and
10 mMCuPhen, we held the patch for 40ms in the fourth barrel of our perfusion
tool applying only normal solution in the presence of CTZ, in order to wash out
the antagonist, before assessing the extent of trapping (Figure S4). We
assessed the effects of modification by calculating the active fraction (Af):
Af = 1 Islow
Ipre
;
where Islow is the amplitude of the slow component of the double exponential fit
to the current immediately following CuPhen treatment, and Ipre is the peak
current before treatment. The kinetics of trapping was analyzed by fitting a
single exponential equation to the active fraction obtained at different times
of exposure to CuPhen. To independently analyze the rate of modification,
we fitted a single exponential equation to the current in the presence of
10 mM CuPhen and 500 mM glutamate. To assess state-dependent zinc
bridging, we used similar protocols but held the patches in 2 mM EDTA
to chelate all divalent ions and thus prevent bridging, and exposed them to
1 mM zinc to induce bridging. Trapping was assessed at +60 and 60 mV
to ensure that it was voltage independent.
We measured concentration-response curves in the A665C mutant at the
beginning of the application of oxidizing conditions (peak, when the receptors
were still reduced) and in steady-state oxidizing conditions, when we assumed
trapping was complete. We obtained the EC50 from fits to the Hill equation:
I
Imax
=
½Glun
½Glun +ECn50
;
where n is the Hill coefficient, and [Glu] is glutamate concentration. We
measured trapping after the application of CuPhen in different concentrations
of glutamate, plotting the immediate active fraction of the current against
different concentrations of glutamate. This was normalized against the current
following oxidizing conditions plus 10 mM glutamate. A log normal function
was fitted to the data.
Construction of a Receptor Lacking Free Cysteines
The GluA2 receptor contains 11 cysteines, 4 of them involved in disulfide
bonds (C63 with C315 and C718 with C773C). In order to obtain a construct502 Neuron 79, 492–503, August 7, 2013 ª2013 Elsevier Inc.running monomerically under denaturing conditions, we serially removed
free cysteines, eventually constructing the 7 3 Cys() mutant by introducing
the following mutations into the GluA2 WT receptor: C89S, C190A, C436S,
C425S, C528S, C589S, and C815S (Figure S3A). This channel remained func-
tional and had similar properties toWT (Figure S3B). All cysteine mutants stud-
ied by western blotting were made on this background. All mutations were
introduced by overlap PCR and confirmed by double-stranded sequencing.
Biochemistry
HEK293T cells were plated in 10 cm dishes and transfected with different plas-
mids (5 mg) using polyethylenimine (PEI; 1 mg/ml). After 72 hr, cells were
collected in PBS, centrifuged 5 min at 1,000 3 g, and pellets were resus-
pended in a buffer containing 300 mM NaCl, 50 mM Tris (pH 8), 1% DDM
(Anatrace), and a protease inhibitor mixture (Roche). For treatments under
reducing and oxidizing conditions, dishes were rinsed with PBS followed by
incubation with 100 mM DTT or 100 mM CuPhen in serum-free medium for
30 min before lysis. After sonication, the lysates were rotated (10 rpm) for
1 hr at 4C and subsequently centrifuged at 20,000 3 g to obtain cleared
lysates. Protein extracts (50 mg) were then separated by 4%–12% Bis-Tris
Glycine SDS/PAGE and transferred to nitrocellulose membranes. Blots were
immunostained overnight at 4C, or for 5 hr at RT, with anti-GluA2 N terminus
(1:1,000; Millipore) or anti-b-actin (1:2,000; Cell Signaling) primary antibodies.
Following exposure to appropriate peroxidase-conjugated secondary anti-
bodies (Biozol), blots were visualizedwith chemiluminescence reagent (Super-
Signal West Pico; Thermo Scientific). Densitometric analysis was performed
using ImageJ (Schneider et al., 2012). The signal from b-actin was used as a
loading control, and the results were normalized as the ratio of dimer band
intensity versus the total intensity of dimer and monomer bands. Statistical
significance across conditions (one-way ANOVA) was assessed with
Dunnett’s post hoc test in KaleidaGraph (Synergy Software).
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